BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
34 hedge funds and large institutions have $6.34M invested in Baudax Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+8
Holders Change %
+30.77%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
9
Reduced
6
Closed
6
Calls
$88K
Puts
$28K
Net Calls
+$60K
Net Calls Change
+$255K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$3.54M |
| 2 |
Renaissance Technologies
New York
|
+$391K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$223K |
| 4 |
D.E. Shaw & Co
New York
|
+$134K |
| 5 |
Two Sigma Investments
New York
|
+$128K |
